Cure Pharmaceutical: From OTC to NASDAQ
Coming from the OTC Markets, Cure Pharmaceutical Holding will sell shares at the NASDAQ Capital Market under the symbol “CURR.” ...
Tag: NASDAQ
FEATURED NEWS
CbdMD Appears To Be Quite Undervalued At 1.5x-2x salesAssuming 2020 sales growth of 100%, CbdMD sells at 1.5x-2x sales, which I believe is cheap. Remember that a few months ago, cannabis operators were trading at more than 100x sales. The company has …
Lizhi Represents Buying Opportunity At 2.33x Sales# Report: Lizhi_Is_A_Buy — Previous Financial Analysis: # Equity Research Report: BANGI, Inc. (OTCMKTS: BNGI) Growing Through Acquisitions # Lennox International (NYSE: LII): We Don’t Like The …
Kandi Technologies: I Am A Bit SkepticalWhile KNDI (KNDI) appears quite cheap at 1.5x 2020 sales, I am quite skeptical about the company’s future. Both the Coronavirus and the decline in the oil price are not great for the stock. The …
Babcock: The Market Did Not React To The Decline In The Oil PriceBabcock & Wilcox Enterprises (BW) is executing a turnaround, and the market expects profitability in 2020 and 2021. However, minority shareholders may not benefit from the expected EBITDA …
© 2017 Stock Market Revolution - The secret of freedom lies in educating people, whereas the secret of tyranny is in keeping them ignorant.
